Literature DB >> 10391432

Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness.

W G Honer1, P Falkai, C Chen, V Arango, J J Mann, A J Dwork.   

Abstract

Abnormalities of proteins involved in neurotransmission and neural plasticity at synapses are reported in schizophrenia, and may be markers of dysregulated neural connectivity in this illness. Studies of brain development and neural regeneration indicate a dynamic interplay between neural and oligodendroglial mechanisms in regulating synaptic plasticity and axonal sprouting. In the present study, markers of synapses (synaptophysin), plasticity (growth-associated protein-43) and oligodendrocytes (myelin basic protein) were investigated in anterior frontal cortex homogenates from individuals with schizophrenia and depression. Synaptophysin immunoreactivity was reduced in schizophrenics who died of natural causes relative to controls. Myelin basic protein immunoreactivity was decreased in both schizophrenics and depressed individuals who died by suicide. Overall, no changes were observed in growth-associated protein-43 immunoreactivity. However, a slight increase in immunoreactivity in depressed suicides relative to control was observed. These findings support the hypothesis that synaptic abnormalities are a substrate for disordered connectivity in severe mental illness, and suggest that synaptic-oligodendroglial interactions may contribute to the mechanism of dysregulation in certain cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391432     DOI: 10.1016/s0306-4522(98)00679-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  52 in total

Review 1.  Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue.

Authors:  B Dean
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

2.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 4.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

5.  Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.

Authors:  YongXin Hao; Aref Shabanpoor; Gerlinde A Metz
Journal:  Neurosci Lett       Date:  2017-05-01       Impact factor: 3.046

6.  Proteomics as a tool for understanding schizophrenia.

Authors:  Daniel Martins-de-Souza
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-12-31       Impact factor: 2.582

7.  Impaired musical ability in people with schizophrenia.

Authors:  Sanae Hatada; Ken Sawada; Masanori Akamatsu; Erina Doi; Masayoshi Minese; Motoshi Yamashita; Allen E Thornton; William G Honer; Shimpei Inoue
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

Review 8.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Authors:  Jose J Miguel-Hidalgo; Angela Whittom; Ashley Villarreal; Madhav Soni; Ashish Meshram; Jason C Pickett; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

10.  Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.

Authors:  Clare L Beasley; Andrew J Dwork; Gorazd Rosoklija; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasa Davceva; Andrew R Tait; Suzana K Straus; William G Honer
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.